In a study comparing 160 mg aspirin (acetylsalicylic acid) administered after acute myocardial infarction versus placebo, mortality at 5 weeks was 9 % in the aspirin group and 12 % in the placebo group. What is the number needed to treat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Number Needed to Treat Calculation

The number needed to treat (NNT) is 33 (Option C), calculated from the absolute risk reduction of 3% (12% mortality in placebo minus 9% mortality in aspirin group).

Calculation Method

The NNT is derived using the following formula:

  • Absolute Risk Reduction (ARR) = Control Event Rate - Treatment Event Rate
  • ARR = 12% - 9% = 3% = 0.03
  • NNT = 1 / ARR = 1 / 0.03 = 33.3 ≈ 33 1, 2

Clinical Context

This calculation is based on the landmark ISIS-2 trial, which demonstrated that 160 mg daily aspirin for one month after acute myocardial infarction reduced 5-week vascular mortality from 12.0% to 9.4% (representing a 23% relative odds reduction) 1, 2.

Key Trial Findings:

  • The study enrolled 17,187 patients with suspected acute myocardial infarction across 417 hospitals 1, 2
  • Aspirin alone produced highly significant mortality reduction (p < 0.00001) 1
  • When combined with streptokinase, the mortality benefit was even greater (8.0% vs 13.2% with neither agent), demonstrating additive effects 1, 2
  • Aspirin significantly reduced non-fatal reinfarction (1.0% vs 2.0%) and non-fatal stroke (0.3% vs 0.6%) without significant increase in cerebral hemorrhage 1

Safety Profile:

  • Aspirin was not associated with significant increases in bleeds requiring transfusion or cerebral hemorrhage in this post-MI population 1, 2
  • The bleeding risk was substantially lower than with streptokinase alone 1

This NNT of 33 means that treating 33 patients with acute myocardial infarction with 160 mg aspirin daily for 5 weeks would prevent one vascular death 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.